ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Ticker Update

Updates

SUB-TYPE:

15th July 2020

Recall on PHE TYPE IIR FACEMASKS

Although these masks meet the breathability, filtration and splash resistance requirements of BS EN 14683, in light of ongoing monitoring, further complaints reported and testing from the manufacturer on the masks. There is a risk to staff wearing the mask if the foam strip on the mask flakes and enters their airway or mouth. There have also been complaints of the ties and/or stitching coming away from the mask.

 

Please return all affected stock to Alliance Healthcare for replacement stock only. No credit will be issued as part of this Recall. Replacement stock will be issued once received from Department of Health and Social Care.

 

Please ensure that all stock is returned by Wednesday 22nd of July 2020 any stock returned after this date will not be eligible for replacement.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierLiveryAffected Batch
8019622PHE TYPE IIR FACEMASKSDepartment of Health and Social CareCardinalPlease see below

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

 

If you have any questions, then please contact your local Service Centre Customer Services team.

 

Annex 1 – Lot numbers of BWM028 Cardinal Type IIR masks 0120GLP09 0517CLP10 0302FLP09 0517JLP09 0305HLP09 0518CLP10 0310GLP09 0518LLP09 0321FLP09 0518LLP09 0321FLP09 0519ALP10 0327FLP09 0519KLP09 0402HLP09 0519MLP09 0408HLP09 0520CLP10 0411FLP09 0520JLP09 0411HLP09 0520LLP09 0413HLP09 0521KLP09 0416HLP09 0521MLP09 0419HLP09 0522ALP10 0422HLP09 0522LLP09 0425HLP09 0523CLP10 0428HLP09 0523JLP09 0431HLP09 0523MLP09 0501ALP10 0524KLP09 0502BLP10 0524LLP09 0502CLP10 0525ALP10 0502LLP09 0525JLP09 0503DLP10 0526CLP10 0503JLP09 0526LLP09 0503KLP09 0526MLP09 0504ALP10 0527KLP09 0504LLP09 0528JLP09 0505BLP10 0528LLP09 0506ALP10 0529CLP10 0506JLP09 0529KLP09 0506KLP09 0529MLP09 0506LLP09 0530JLP09 0508DLP10 0531CLP10 0508KLP09 0531KLP09 0508MLP09 0509JLP09 0510KLP09 0511ALP10 0511JLP09 0511MLP09 0513ALP10 0513KLP09 0513MLP09 0514JLP09 0516ALP10 0516KLP09 0516MLP09

 

Alliance Healthcare News

SUB-TYPE: CLASS 2 RECALL

15th July 2020

Class 2 Recall on Desmopressin Nasal Spray (All Strengths)

Ferring Pharmaceuticals Limited is recalling all unexpired stock of the below batches of products from pharmacies and wholesalers as a precautionary measure due to a lower volume of solution being observed in the bottles, and out of specification results for the content of the desmopressin acetate (active substance) and benzalkonium chloride (excipient).

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionLiveryAffected Batch
Alliance do not stockDesmospray 0.1 mg/ml Nasal SprayFerring PharmaceuticalsPlease follow MHRA Link
Alliance do not stockOctim® 1.5mg/ml Nasal Spray SolutionFerring PharmaceuticalsPlease follow MHRA Link
8415408Desmopressin Nasal Spray 10mcgAspire PharmaPlease follow MHRA Link
1060946Desmopressin Nasal Spray 10mcgAspire PharmaPlease follow MHRA Link

Please note that Alliance Healthcare do not stock either Ferring line and we are not accepting stock returns on these. We are accepting stock returns on the Aspire Livery Desmopressin.

For stock control queries, please contact Customer.Services@Ferring.com 0800 111 4125

For Aspire livery stock (Desmopressin 0.1 mg/ml Nasal Spray, PL 03194/0090), please contact customerservices@aspirepharma.co.uk 01730 231148

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

15th July 2020

Class 2 Recall on Nitrofurantoin Tablets 50mg

Dr Reddy's Laboratories (UK) Limited is recalling all unexpired stock of the above batch of Nitrofurantoin 50mg Tablets from pharmacies and wholesalers as a precautionary measure due to out of specification results for dissolution during routine stability testing.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionLiveryAffected Batch
1203009NITROFURANTOIN TAB 50MGDr Reddy's0273669
1085083NITROFURANTOIN TAB 50MGDr Reddy's0273669
8085219NITROFURANTOIN TAB 50MGDr Reddy's0273669
1117225NITROFURANTOIN TAB 50MGDr Reddy's0273669

 

For medical information enquiries please contact Dr. Reddy's Laboratories (UK) Ltd Medical Information Department at 01748 828873, or email drreddysGB@EU.ProPharmaGroup.com

For stock control enquiries please contact Dr. Reddy's Laboratories (UK) Ltd Customer Services Team at 01482 389858 (or main switchboard at 01482 860228), or email customerserviceuk@drreddys.com

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

02nd July 2020

Class 2 Recall on Mepacrine Hydrochloride 100 Mg Tablets

BCM Specials Limited has informed us that a number of foreign body particulates including glass and rubber have been found in one of the containers of the Active Pharmaceutical Ingredient (API) used in the manufacture of Mepacrine Hydrochloride 100mg tablets. A small amount of the affected API (comparative to the API present in batch 85641) has been used in the manufacture of batch 85641 Mepacrine Hydrochloride tablets.

 

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
8463366MEPACRINE TABS 100MGBCM Specials Limited85641

For stock control queries please contact BCM Specials Limited., Telephone +44 (0)115 968 6075 or email specials.regulatory.bcm@fareva.com.

For any medical information enquires please contact BCM Specials Limited., Telephone +44 (0)115 968 6075 or email specials.regulatory.bcm@fareva.com.

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 4 CAUTION IN USE

30th June 2020

Class 4 Caution in Use on Depo-Provera 150mg/Ml Injection (1ml Vial)

Drugsrus Ltd (distributor) / Tenolol Ltd (MA Holder) has informed us of a typographical error in active ingredient stated on the label on the vial. The active ingredient should be "medroxyprogesterone acetate" (a long acting contraceptive) however, it is stated as "methylpredinisolone acetate" (a corticosteroid) in error.

 

Please visit the: MHRA website for more details on this drug alert.

 

The affected products' details are as follows:

 

PIP CodeProduct DescriptionSupplierAffected Batch

 

Alliance do not stockDepo-Provera 150mg/Ml Injection (1ml Vial)Drugsrus Ltd (distributor) / Tenolol Ltd (MA Holder)AT0604
X44095

 

Alliance healthcare do not stock this product and as this is a caution in use only we are not accepting stock returns.



For more information or medical information enquiries please contact info@drugsrus.co.uk or call on 020 8423 3800

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

08th June 2020

Class 2 Recall on Epistatus 10mg/mL Oromucosal

Torbay Pharmaceuticals has informed us that the child-resistant container closure for Epistatus 10mg/mL Oromucosal Solution (Multi Dose Bottles) may be faulty and incorrectly engaged. The child resistant closure can potentially be removed without unscrewing the cap closure. Removal of an incorrectly engaged cap closure will result in the yellow tamper evident band not being retained on the neck of the bottle. It should be noted that this product is manufactured as an unlicensed special..

 

Please visit the: MHRA website for more details on this drug alert.

 

The affected products' details are as follows:

 

PIP CodeProduct DescriptionSupplierAffected Batch
8462848EPISTATUS BUCCAL 10MG/MLTorbay Pharmaceuticals (for Veriton Pharma Ltd)191111C
200113C

 

For stock control queries please contact Veriton Pharma Ltd., Telephone +44 (0)1932 690325 or emailinfo@veritonpharma.com



For any medical information enquires please contact Veriton Pharma Ltd., Telephone +44 (0)1932690325 or email info@veritonpharma.com

 

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

 

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 4 CAUTION IN USE

28th May 2020

Class 4 Caution in use Sodium Benzoate (Amzoate) 2g in 10 mL Sterile Solution for injection

Torbay Pharmaceuticals has informed us that the carton label on Sodium Benzoate (Amzoate) 2g in 10 mL Sterile Solution for injection incorrectly states the concentration of disodium edetate (excipient) as 0.1% w/v (10mg in 1mL) instead of 0.1% w/v (10mg in 10mL).

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
Alliance do not stockSodium Benzoate (Amzoate) 2g in 10 mL Sterile Solution for injectionTorbay Pharmaceuticals (for Veriton Pharma Ltd)Please refer to MHRA website

For stock control queries please contact Torbay Pharmaceuticals, Telephone +44 (0)1803 664707 or email torbaypharmaceuticals@nhs.net

For any medical information enquires please contact Torbay Pharmaceuticals, Telephone +44 (0)1803 664707 or email torbaypharmaceuticals@nhs.net

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

This is a caution in use only and we do not stock this line therefore we are not accepting stock returns.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

18th May 2020

Class 2 Recall on Emerade 500 microgram auto-injectors

Pharmaswiss Ceska republika s.r.o. (an affiliate of Bausch & Lomb UK Limited) is recalling all unexpired batches of Emerade 500 microgram auto-injectors (also referred to as pens) from patients due to an error in one component of the auto-injector believed to cause some pens to fail to activate and deliver adrenaline.

 

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
3849247EMERADE 500 AUTO-INJECTORBAUSCH & LOMB UKALL STOCK

For stock enquiries please contact Bausch & Lomb Customer Services, Tel: 020 8781 2991

For medical information enquiries please contact the Pharmacovigilance and Medical Information Officer, Tel: 0208 781 5523, Email: Pharmacovigilance.UK@bausch.com

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please note that Alliance Healthcare do not stock and we are not accepting stock returns.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 4 CAUTION IN USE

20th April 2020

Class 4 Caution in Use on GSK various products

GSK has informed us that due to a machinery defect with the printing line, a small number of packs may not have the batch number and expiry date printed on the outer cartons. The correct information is printed on the blister pack and there is no concern with the product quality.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
2881316BEECHAMS AIO TABLETSGLAXO SMITH KLINEPLEASE REFER TO MHRA WEBSITE
2847317PIRITEZE ALLERGY ONE-A-DAY TABGLAXO SMITH KLINEPLEASE REFER TO MHRA WEBSITE
4093456PIRITEZE ALLERGY TABLETSGLAXO SMITH KLINEPLEASE REFER TO MHRA WEBSITE
4093449PIRITEZE TABLET ALLERGY 30SGLAXO SMITH KLINEPLEASE REFER TO MHRA WEBSITE
2132074PIRITON ALLERGY TABLETSGLAXO SMITH KLINEPLEASE REFER TO MHRA WEBSITE
3339199PIRITON ALLERGY TABLETSGLAXO SMITH KLINEPLEASE REFER TO MHRA WEBSITE
0076083DAY NURSE CAPGLAXO SMITH KLINEPLEASE REFER TO MHRA WEBSITE
0092767NIGHT NURSE CAPSGLAXO SMITH KLINEPLEASE REFER TO MHRA WEBSITE

This may have been supplied by AHDL. Unfortunately we are not providing specific batch information you will be required to follow the instructions as per the drug alert

For more information or medical information queries, please contact GSK Customer Relations at 0800783 8881 or email customer.relations@gsk.com

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

This is a caution in use only we are not accepting stock returns.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 4 CAUTION IN USE

16th April 2020

Class 4 Caution in Use on Levofloxacin 500mg Tablets

TEVA UK Limited has informed us that the Product Code/GTIN (PC) number found on the above batches is incorrect. The GTIN number that should have been allocated for this batch of tablets is 05017007064459, however, 05017007064435 was applied in error which scans the batches as Levofloxacin 250mg Tablets. The product packed, the blister primary data, PIL primary data and carton primary data were confirmed as correct for a Levofloxacin 500mg Tablet batch.

 

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
8426322LEVOFLOXACIN TAB 500MGTEVA UK105362
1159250LEVOFLOXACIN TAB 500MGTEVA UK105362
1162205LEVOFLOXACIN TAB 500MGTEVA UK105362
1161645LEVOFLOXACIN TAB 500MGTEVA UK105362

For customer services queries, please contact general.enquiries@tevauk.com or telephone the Freephone number 0800 590 502

For medical enquiries and/or suspected adverse reaction reporting, please contact medinfo@tevauk.com or telephone 020 7540 7117

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

This may have been supplied by AHDL. Unfortunately we are not providing specific batch information you will be required to follow the instructions as per the drug alert.

This is a caution in use only we are not accepting stock returns

If you have any questions, then please contact your local Service Centre Customer Services team.